| Row | Study Title | Conditions | Interventions | Detail |
|---|---|---|---|---|
| 222 | Stability of Implants Placed in Patients With Vitamin D Deficiency Using Sequential Drilling vs a Single Drilling Design | Implant Stability With Vitamin D Deficiency |
Procedure:sequential drilling technique |
detail |
| 223 | Evaluation of Root Coverage After the Use of Coronally Advanced Flap Either With Advanced Paltelet Rich Fibrin or Subepithilial Connective Tissue Graft in Treatment of Miller Class I and II Gingival Recession. | Gingival Recession |
Procedure:CAF + (A-PRF) Procedure:CAF+SCTG |
detail |
| 225 | PLAY (PhysicaL ActivitY) Policy Study | Motor Activity |
Behavioral:PLAY (PhysicaL ActivitY) Policy Intervention |
detail |
| 226 | Afatinib and Pembrolizumab for Head and Neck Squamous Cell Carcinoma (ALPHA Study) | Head and Neck Neoplasms |
Drug:Afatinib Oral Tablet Drug:Pembrolizumab Injection |
detail |
| 227 | Direct Anterior Approach for Femoral Neck Fractures | Femoral Neck Fractures |
Procedure:Direct anterior approach Procedure:Direct Lateral Approach |
detail |
| 228 | Registry Evaluating AF Ablation Techniques | Atrial Fibrillation|Catheter Ablation |
: |
detail |
| 229 | Pembrolizumab in Treating Patients With Stage IB-IV Mycosis Fungoides | Mycosis Fungoides|Sezary Syndrome|Stage IB Mycosis Fungoides and Sezary Syndrome AJCC v8|Stage II Mycosis Fungoides and Sezary Syndrome AJCC v8|Stage IIA Mycosis Fungoides and Sezary Syndrome AJCC v8|Stage IIB Mycosis Fungoides and Sezary Syndrome AJCC v8|Stage III Mycosis Fungoides and Sezary Syndrome AJCC v8|Stage IIIA Mycosis Fungoides and Sezary Syndrome AJCC v8|Stage IIIB Mycosis Fungoides and Sezary Syndrome AJCC v8|Stage IV Mycosis Fungoides and Sezary Syndrome AJCC v8|Stage IVA1 Mycosis Fungoides and Sezary Syndrome AJCC v8|Stage IVA2 Mycosis Fungoides and Sezary Syndrome AJCC v8|Stage IVB Mycosis Fungoides and Sezary Syndrome AJCC v8 |
Biological:Pembrolizumab |
detail |
| 230 | Local and Systemic Effects of Photobiomodulation Therapy on Muscle Performance and Recovery Post-exercise. | Phototherapy|Low-level Laser Therapy|Systemic |
Device:Phototherapy |
detail |
| 231 | Safety of Norepinephrine Administered Through Peripheral Venous Catheter | Hypotension |
Drug:Peripheral administration of Norepinephrine |
detail |
| 233 | Prevalence of New Psychoactive Substances Use | Addiction |
: |
detail |
京公网安备 11010102003638号